CN115010617A - 一种碘帕醇的制备方法 - Google Patents
一种碘帕醇的制备方法 Download PDFInfo
- Publication number
- CN115010617A CN115010617A CN202210819256.XA CN202210819256A CN115010617A CN 115010617 A CN115010617 A CN 115010617A CN 202210819256 A CN202210819256 A CN 202210819256A CN 115010617 A CN115010617 A CN 115010617A
- Authority
- CN
- China
- Prior art keywords
- sba
- molecular sieve
- iopamidol
- solid
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960004647 iopamidol Drugs 0.000 title claims abstract description 33
- XQZXYNRDCRIARQ-LURJTMIESA-N iopamidol Chemical compound C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I XQZXYNRDCRIARQ-LURJTMIESA-N 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 239000002808 molecular sieve Substances 0.000 claims abstract description 34
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims abstract description 34
- 238000000034 method Methods 0.000 claims abstract description 24
- 238000006243 chemical reaction Methods 0.000 claims abstract description 15
- ALHZEIINTQJLOT-UHFFFAOYSA-N (1-chloro-1-oxopropan-2-yl) acetate Chemical compound ClC(=O)C(C)OC(C)=O ALHZEIINTQJLOT-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 38
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 17
- 238000005406 washing Methods 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 16
- 239000000047 product Substances 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 12
- 238000000926 separation method Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000000746 purification Methods 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000009210 therapy by ultrasound Methods 0.000 claims description 3
- 239000011148 porous material Substances 0.000 claims description 2
- 238000001354 calcination Methods 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 abstract description 5
- 230000008025 crystallization Effects 0.000 abstract description 5
- 238000006555 catalytic reaction Methods 0.000 abstract 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- 238000001514 detection method Methods 0.000 description 16
- 239000012535 impurity Substances 0.000 description 13
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 10
- 230000003287 optical effect Effects 0.000 description 10
- ALHZEIINTQJLOT-VKHMYHEASA-N [(2s)-1-chloro-1-oxopropan-2-yl] acetate Chemical compound ClC(=O)[C@H](C)OC(C)=O ALHZEIINTQJLOT-VKHMYHEASA-N 0.000 description 7
- 239000011347 resin Substances 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- FBJVWRITWDYUAC-UHFFFAOYSA-N 5-amino-2,4,6-triiodobenzene-1,3-dicarbonyl chloride Chemical compound NC1=C(I)C(C(Cl)=O)=C(I)C(C(Cl)=O)=C1I FBJVWRITWDYUAC-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 238000005917 acylation reaction Methods 0.000 description 5
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 239000002872 contrast media Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- -1 (S) -2- (acetoxy) propanoyl Chemical group 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000010933 acylation Effects 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 238000004808 supercritical fluid chromatography Methods 0.000 description 3
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- KJJPLEZQSCZCKE-UHFFFAOYSA-N 2-aminopropane-1,3-diol Chemical compound OCC(N)CO KJJPLEZQSCZCKE-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 230000006340 racemization Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- NGSUSCJBVJPDRE-UHFFFAOYSA-N 1,3-dioxane-5-carboxamide Chemical compound NC(=O)C1COCOC1 NGSUSCJBVJPDRE-UHFFFAOYSA-N 0.000 description 1
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 1
- BOGCXPVULYNZEK-UHFFFAOYSA-N 2-aminopropane-1,3-diol Chemical compound OCC(N)CO.OCC(N)CO BOGCXPVULYNZEK-UHFFFAOYSA-N 0.000 description 1
- FVLWRKHQMFPOQE-UHFFFAOYSA-N 5-amino-1-n,3-n-bis(1,3-dihydroxypropan-2-yl)-2,4,6-triiodobenzene-1,3-dicarboxamide Chemical compound NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I FVLWRKHQMFPOQE-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- ALHZEIINTQJLOT-GSVOUGTGSA-N [(2r)-1-chloro-1-oxopropan-2-yl] acetate Chemical compound ClC(=O)[C@@H](C)OC(C)=O ALHZEIINTQJLOT-GSVOUGTGSA-N 0.000 description 1
- GUUCJQVOLIWIFP-UHFFFAOYSA-N [3-acetyloxy-2-[[3-amino-5-(1,3-diacetyloxypropan-2-ylcarbamoyl)-2,4,6-triiodobenzoyl]amino]propyl] acetate Chemical compound CC(=O)OCC(COC(C)=O)NC(=O)C1=C(I)C(N)=C(I)C(C(=O)NC(COC(C)=O)COC(C)=O)=C1I GUUCJQVOLIWIFP-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000003857 carboxamides Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000012069 chiral reagent Substances 0.000 description 1
- 230000020176 deacylation Effects 0.000 description 1
- 238000005947 deacylation reaction Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J29/00—Catalysts comprising molecular sieves
- B01J29/005—Mixtures of molecular sieves comprising at least one molecular sieve which is not an aluminosilicate zeolite, e.g. from groups B01J29/03 - B01J29/049 or B01J29/82 - B01J29/89
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2229/00—Aspects of molecular sieve catalysts not covered by B01J29/00
- B01J2229/10—After treatment, characterised by the effect to be obtained
- B01J2229/18—After treatment, characterised by the effect to be obtained to introduce other elements into or onto the molecular sieve itself
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J29/00—Catalysts comprising molecular sieves
- B01J29/03—Catalysts comprising molecular sieves not having base-exchange properties
- B01J29/0308—Mesoporous materials not having base exchange properties, e.g. Si-MCM-41
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J29/00—Catalysts comprising molecular sieves
- B01J29/03—Catalysts comprising molecular sieves not having base-exchange properties
- B01J29/0308—Mesoporous materials not having base exchange properties, e.g. Si-MCM-41
- B01J29/0316—Mesoporous materials not having base exchange properties, e.g. Si-MCM-41 containing iron group metals, noble metals or copper
- B01J29/0333—Iron group metals or copper
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210819256.XA CN115010617A (zh) | 2022-07-11 | 2022-07-11 | 一种碘帕醇的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210819256.XA CN115010617A (zh) | 2022-07-11 | 2022-07-11 | 一种碘帕醇的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115010617A true CN115010617A (zh) | 2022-09-06 |
Family
ID=83080224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210819256.XA Pending CN115010617A (zh) | 2022-07-11 | 2022-07-11 | 一种碘帕醇的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115010617A (zh) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6100425A (en) * | 1996-12-24 | 2000-08-08 | Bracco International, B.V. | Process for the preparation of an intermediate useful in the synthesis of iodinated contrast media |
US20010056206A1 (en) * | 1999-02-26 | 2001-12-27 | Richard Lorenzini | Process for the preparation of iopamidol |
CN1478068A (zh) * | 2000-12-01 | 2004-02-25 | 制备碘帕醇的方法和其中的新中间体 | |
CN103382160A (zh) * | 2012-05-02 | 2013-11-06 | 上海海神化学生物科技有限公司 | 碘帕醇的合成及其合成中间体的制备 |
US20140155648A1 (en) * | 2011-06-24 | 2014-06-05 | Hovione Inter Limited | Manufacture of a Triiodinated Contrast Agent |
US20160237026A1 (en) * | 2013-11-05 | 2016-08-18 | Bracco Imaging S.P.A. | Process for the preparation of iopamidol |
WO2022002953A1 (en) * | 2020-06-29 | 2022-01-06 | Ge Healthcare As | Process for the preparation of iopamidol |
CN114656370A (zh) * | 2022-03-29 | 2022-06-24 | 海南普利制药股份有限公司 | 一种碘帕醇中间体的精制方法 |
-
2022
- 2022-07-11 CN CN202210819256.XA patent/CN115010617A/zh active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6100425A (en) * | 1996-12-24 | 2000-08-08 | Bracco International, B.V. | Process for the preparation of an intermediate useful in the synthesis of iodinated contrast media |
US20010056206A1 (en) * | 1999-02-26 | 2001-12-27 | Richard Lorenzini | Process for the preparation of iopamidol |
JP4540233B2 (ja) * | 1999-02-26 | 2010-09-08 | ブラツコ・イメージング・エツセ・ピー・アー | イオパミドールの製造方法 |
CN1478068A (zh) * | 2000-12-01 | 2004-02-25 | 制备碘帕醇的方法和其中的新中间体 | |
US20140155648A1 (en) * | 2011-06-24 | 2014-06-05 | Hovione Inter Limited | Manufacture of a Triiodinated Contrast Agent |
CN103382160A (zh) * | 2012-05-02 | 2013-11-06 | 上海海神化学生物科技有限公司 | 碘帕醇的合成及其合成中间体的制备 |
US20160237026A1 (en) * | 2013-11-05 | 2016-08-18 | Bracco Imaging S.P.A. | Process for the preparation of iopamidol |
WO2022002953A1 (en) * | 2020-06-29 | 2022-01-06 | Ge Healthcare As | Process for the preparation of iopamidol |
CN114656370A (zh) * | 2022-03-29 | 2022-06-24 | 海南普利制药股份有限公司 | 一种碘帕醇中间体的精制方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5775524B2 (ja) | イオジキサノールの調製及び精製 | |
EP3828170A1 (en) | Method for safely preparing pimavanserin and tartrate salt thereof using triphosgene | |
JP6248119B2 (ja) | X線造影剤の中間体の製造 | |
CN108676014A (zh) | 纯化依维莫司中间体的方法以及制备依维莫司的方法 | |
JPH03200753A (ja) | 光学純度の高い光学活性アテノロール塩及びアテノロールの製法 | |
KR20110009039A (ko) | 비-이온성 x-선 조영제의 합성에서 연속 탈아세틸화 및 정제 방법 | |
CN115010617A (zh) | 一种碘帕醇的制备方法 | |
JP2000517312A (ja) | イオヘキソールの製法 | |
JPH11510827A (ja) | イオパミドールの調製中の中間体の精製方法 | |
JP2747967B2 (ja) | シアル酸粉末 | |
CN110878079A (zh) | 一种高纯度依利格鲁司他的制备方法 | |
JP6783140B2 (ja) | 非イオン性x線造影剤の合成における代替アセチル化方法 | |
JP2011068611A (ja) | 4−アミノ−5−クロロ−2−エトキシ−n−〔[4−(4−フルオロベンジル)−2−モルホリニル]メチル〕ベンズアミドの精製方法 | |
KR100885677B1 (ko) | 디아세레인의 정제 방법 | |
JP6275596B2 (ja) | テルミサルタンのアンモニウム塩の製造方法 | |
CN112694488B (zh) | 一种l型头孢孟多酯钠的合成方法 | |
JP5419570B2 (ja) | 2−アセチルアミノメチル−4−(4−フルオロベンジル)モルホリンの精製方法 | |
JP4895510B2 (ja) | バリオールアミンの製造方法 | |
JPH06340599A (ja) | 光学活性2−アミノ酪酸の製法 | |
CN106866641A (zh) | 一种阿法替尼的精制方法 | |
CN108299468A (zh) | 一种头孢丙烯的精制方法 | |
JPS58188862A (ja) | N−アシルカルノシンの製造法 | |
CN117304212A (zh) | 一种头孢卡品酯杂质的制备方法 | |
JP2020083892A (ja) | ベラプロスト−314d・一水和物結晶及びその製造方法 | |
CN115124552A (zh) | 去乙酰头孢硫脒的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240117 Address after: No. 58 Xiahong Road, High tech Industrial Development Zone, Anqing City, Anhui Province, 246002 Applicant after: Anhui Puli Pharmaceutical Co.,Ltd. Address before: 246000 No. 58, xiahong Road, high tech Industrial Development Zone, Anqing City, Anhui Province Applicant before: Anhui Puli Pharmaceutical Co.,Ltd. Applicant before: HAINAN POLY PHARM. Co.,Ltd. Applicant before: ZHEJIANG POLY PHARMACEUTICAL Co.,Ltd. |